✦ LIBER ✦

Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease

✍ Scribed by S. Schäfer; O. Wirths; G. Multhaup; T. A. Bayer

Publisher: Springer
Year: 2006
Tongue: English
Weight: 171 KB
Volume: 114
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-006-0580-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Axonopathy in an APP/PS1 transgenic mous

Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease

✍ Oliver Wirths; Joachim Weis; Jacek Szczygielski; Gerd Multhaup; Thomas A. Bayer 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 1006 KB

Effects of Cerebrolysin™ on neurogenesis

Effects of Cerebrolysin™ on neurogenesis in an APP transgenic model of Alzheimer’s disease

✍ Edward Rockenstein; Michael Mante; Anthony Adame; Leslie Crews; Herbert Moessler 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 696 KB

Immunotherapeutic approaches for Alzheim

Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models

✍ Thomas Wisniewski; Allal Boutajangout 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 352 KB

Focal demyelination in Alzheimer’s disea

Focal demyelination in Alzheimer’s disease and transgenic mouse models

✍ Stanislaw Mitew; Matthew T. K. Kirkcaldie; Glenda M. Halliday; Claire E. Shepher 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 737 KB

APP transgenic modeling of Alzheimer’s d

APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis

✍ Leslie Crews; Edward Rockenstein; Eliezer Masliah 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 601 KB

MRI assessment of neuropathology in a tr

MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease

✍ Joseph A. Helpern; Sang-Pil Lee; Maria F. Falangola; Victor V. Dyakin; Adam Boga 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract The cerebral deposition of amyloid β‐peptide, a central event in Alzheimer's disease (AD) pathogenesis, begins several years before the onset of clinical symptoms. Noninvasive detection of AD pathology at this initial stage would facilitate intervention and enhance treatment success. In